Miljenko V Pilepich

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi request reprint Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma--long-term results of phase III RTOG 85-31
    Miljenko V Pilepich
    University of California, Los Angeles, School of Medicine, Los Angeles, CA, USA
    Int J Radiat Oncol Biol Phys 61:1285-90. 2005
  2. ncbi request reprint Phase III study of pentosanpolysulfate (PPS) in treatment of gastrointestinal tract sequelae of radiotherapy
    Miljenko V Pilepich
    Department of Radiation Oncology, UCLA, Los Angeles, CA, USA
    Am J Clin Oncol 29:132-7. 2006
  3. doi request reprint Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: long-term results of RTOG 8610
    Mack Roach
    Department of Radiation Oncology, University of California San Francisco, 1600 Divisadero St, Suite H1031, San Francisco, CA 94143 1708, USA
    J Clin Oncol 26:585-91. 2008
  4. doi request reprint Cardiovascular mortality and duration of androgen deprivation for locally advanced prostate cancer: analysis of RTOG 92-02
    Jason A Efstathiou
    Department of Radiation Oncology, Massachusetts General Hospital, 100 Blossom Street, Boston, MA 02114, USA
    Eur Urol 54:816-23. 2008
  5. pmc Diabetes and mortality in men with locally advanced prostate cancer: RTOG 92-02
    Matthew R Smith
    Department of Radiation Oncology, Division of Hematology and Oncology, Massachusetts General Hospital, Boston, MA 02114, USA
    J Clin Oncol 26:4333-9. 2008
  6. doi request reprint Older age predicts decreased metastasis and prostate cancer-specific death for men treated with radiation therapy: meta-analysis of radiation therapy oncology group trials
    Daniel A Hamstra
    Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan 48109 5010, USA
    Int J Radiat Oncol Biol Phys 81:1293-301. 2011
  7. ncbi request reprint Race and survival of men treated for prostate cancer on radiation therapy oncology group phase III randomized trials
    Mack Roach
    Department of Radiation Oncology, University of California San Francisco, 1600 Divisadero Street, San Francisco, CA 94143 1708, USA
    J Urol 169:245-50. 2003
  8. pmc Protein kinase A RI-alpha predicts for prostate cancer outcome: analysis of radiation therapy oncology group trial 86-10
    Li Yan Khor
    Department of Radiation Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA
    Int J Radiat Oncol Biol Phys 71:1309-15. 2008
  9. ncbi request reprint Androgen suppression plus radiation versus radiation alone for patients with stage D1/pathologic node-positive adenocarcinoma of the prostate: updated results based on national prospective randomized trial Radiation Therapy Oncology Group 85-31
    Colleen A Lawton
    Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI 53226, USA
    J Clin Oncol 23:800-7. 2005
  10. pmc Obesity and mortality in men with locally advanced prostate cancer: analysis of RTOG 85-31
    Jason A Efstathiou
    Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    Cancer 110:2691-9. 2007

Collaborators

Detail Information

Publications14

  1. ncbi request reprint Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma--long-term results of phase III RTOG 85-31
    Miljenko V Pilepich
    University of California, Los Angeles, School of Medicine, Los Angeles, CA, USA
    Int J Radiat Oncol Biol Phys 61:1285-90. 2005
    ..Radiation Therapy Oncology Group protocol 85-31 was designed to evaluate the effectiveness of adjuvant androgen suppression, using goserelin, in unfavorable prognosis carcinoma of the prostate treated with definitive radiotherapy (RT)...
  2. ncbi request reprint Phase III study of pentosanpolysulfate (PPS) in treatment of gastrointestinal tract sequelae of radiotherapy
    Miljenko V Pilepich
    Department of Radiation Oncology, UCLA, Los Angeles, CA, USA
    Am J Clin Oncol 29:132-7. 2006
    ..To evaluate the effectiveness of pentosanpolysulfate (PPS) in the treatment of gastrointestinal tract sequelae of radiotherapy...
  3. doi request reprint Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: long-term results of RTOG 8610
    Mack Roach
    Department of Radiation Oncology, University of California San Francisco, 1600 Divisadero St, Suite H1031, San Francisco, CA 94143 1708, USA
    J Clin Oncol 26:585-91. 2008
    ..This report summarizes long-term follow-up results...
  4. doi request reprint Cardiovascular mortality and duration of androgen deprivation for locally advanced prostate cancer: analysis of RTOG 92-02
    Jason A Efstathiou
    Department of Radiation Oncology, Massachusetts General Hospital, 100 Blossom Street, Boston, MA 02114, USA
    Eur Urol 54:816-23. 2008
    ....
  5. pmc Diabetes and mortality in men with locally advanced prostate cancer: RTOG 92-02
    Matthew R Smith
    Department of Radiation Oncology, Division of Hematology and Oncology, Massachusetts General Hospital, Boston, MA 02114, USA
    J Clin Oncol 26:4333-9. 2008
    ..Diabetes is associated with lower risk of prostate cancer. Most men with diabetes are obese, and obesity is associated with greater prostate cancer mortality. Whether diabetes influences outcomes after prostate cancer diagnosis is unknown...
  6. doi request reprint Older age predicts decreased metastasis and prostate cancer-specific death for men treated with radiation therapy: meta-analysis of radiation therapy oncology group trials
    Daniel A Hamstra
    Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan 48109 5010, USA
    Int J Radiat Oncol Biol Phys 81:1293-301. 2011
    ....
  7. ncbi request reprint Race and survival of men treated for prostate cancer on radiation therapy oncology group phase III randomized trials
    Mack Roach
    Department of Radiation Oncology, University of California San Francisco, 1600 Divisadero Street, San Francisco, CA 94143 1708, USA
    J Urol 169:245-50. 2003
    ..We assessed the impact of race on survival in men treated with external beam radiotherapy with or without hormonal therapy for localized prostate cancer in Radiation Therapy Oncology Group randomized trials...
  8. pmc Protein kinase A RI-alpha predicts for prostate cancer outcome: analysis of radiation therapy oncology group trial 86-10
    Li Yan Khor
    Department of Radiation Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA
    Int J Radiat Oncol Biol Phys 71:1309-15. 2008
    ....
  9. ncbi request reprint Androgen suppression plus radiation versus radiation alone for patients with stage D1/pathologic node-positive adenocarcinoma of the prostate: updated results based on national prospective randomized trial Radiation Therapy Oncology Group 85-31
    Colleen A Lawton
    Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI 53226, USA
    J Clin Oncol 23:800-7. 2005
    ..To update the effect of immediate androgen suppression in conjunction with standard external-beam irradiation versus radiation alone on a group of histologically lymph node-positive patients with adenocarcinoma of the prostate...
  10. pmc Obesity and mortality in men with locally advanced prostate cancer: analysis of RTOG 85-31
    Jason A Efstathiou
    Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    Cancer 110:2691-9. 2007
    ..Whether BMI is associated with prostate cancer-specific mortality (PCSM) was investigated in a large randomized trial of men treated with RT and androgen deprivation therapy (ADT) for locally advanced prostate cancer...
  11. ncbi request reprint Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group--RTOG 9705
    Jeffrey D Bradley
    Department of Radiation Oncology, Washington University Medical Center, 4921 Parkview Place LL, Mail Stop 90 38 635, St Louis, MO 63110, USA
    J Clin Oncol 23:3480-7. 2005
    ....
  12. pmc Bcl-2 and bax expression and prostate cancer outcome in men treated with radiotherapy in Radiation Therapy Oncology Group protocol 86-10
    Li Yan Khor
    Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
    Int J Radiat Oncol Biol Phys 66:25-30. 2006
    ..In this study we examined bcl-2 and bax expression as predictive markers in men treated with radiotherapy +/- androgen deprivation on Radiation Therapy Oncology Group (RTOG) protocol 86-10...
  13. ncbi request reprint Phase III double-blind study of glutamine versus placebo for the prevention of acute diarrhea in patients receiving pelvic radiation therapy
    Timothy F Kozelsky
    Mayo Clinic, 200 First St, SW, Rochester, MN 55905, USA
    J Clin Oncol 21:1669-74. 2003
    ....
  14. ncbi request reprint Overview of bladder cancer trials in the Radiation Therapy Oncology Group
    William U Shipley
    Genitourinary Oncology Committee, Radiation Therapy Oncology Group, American College of Radiology, Philadelphia, Pennsylvania, USA
    Cancer 97:2115-9. 2003
    ....